WST
West Pharmaceutical Services Inc
371.10$
+2.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.5% | +7.8% | +6.0% | +7.4% | +7.3% | +16.4% | +31.9% | +1.9% | +2.3% | -2.0% | +6.3% | |
| – | -3.0% | +6.8% | +7.8% | +7.8% | +5.4% | +11.7% | +20.2% | +5.4% | +4.1% | +4.0% | +4.2% | |
| – | +1.8% | +9.9% | +2.3% | +6.6% | +11.4% | +26.1% | +52.8% | -2.9% | -0.5% | -11.5% | +10.1% | |
| – | -8.6% | +7.9% | +6.3% | +3.1% | -3.5% | +20.6% | +12.6% | +10.8% | +16.9% | +1.0% | +7.5% | |
| – | +1.9% | +2.9% | +1.2% | +8.4% | +3.7% | +10.7% | +20.1% | -5.3% | +2.8% | -4.2% | +14.8% | |
| – | +0.4% | +3.6% | +1.8% | +3.5% | +6.9% | +12.0% | +18.9% | -9.5% | +12.4% | -3.4% | +19.2% | |
| – | -29.3% | +53.0% | +16.3% | +11.3% | +16.6% | +41.0% | +81.1% | +0.6% | -6.9% | -16.4% | +3.8% | |
| – | -3.8% | -44.0% | -7.1% | +24.6% | -1.2% | +6.3% | +0.0% | -10.6% | +15.8% | -67.0% | -79.3% | |
| – | -31.3% | +63.5% | +17.2% | +11.6% | +21.1% | +39.2% | +83.7% | -8.9% | +2.2% | -16.1% | +2.5% | |
| – | -44.3% | +106.8% | +48.7% | -48.8% | +42.5% | +22.9% | +47.9% | +7.0% | +6.6% | -12.1% | +13.1% | |
| – | -24.8% | +50.2% | +4.9% | +37.3% | +16.8% | +43.2% | +91.2% | -11.5% | +1.3% | -17.0% | +0.2% | |
| – | -19.7% | +31.6% | +13.3% | +8.5% | +14.2% | +28.7% | +69.5% | -8.1% | +4.5% | -11.9% | -2.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.